Clinical Trial

Safety and Performance Evaluation of CPB Venous and Arterial Cannulas

Recruiting
View on ClinicalTrials.gov →
Summary
This is a two-phase study evaluating the Eurosets arterial and venous cannulas for use during cardiopulmonary bypass (CPB) procedures. Phase 1 is a pilot study focused on assessing cannula safety. Phase 2 is a pivotal study aimed at confirming safety and evaluating efficacy through comparison with Medtronic cannulas (control group). The results will be compared for non-inferiority with those obtained using the control group cannulas.
Trial Details
NCT Number NCT07354841
Lead Sponsor Eurosets S.r.l.
Conditions Cardiac Surgery, Heart Surgery, Cardiopulmonary Bypass, Coronary Surgery, Aortic Valve Surgery, Cannulation, Venous Cannulation, Arterial Cannulation +1 more
Enrollment 80 participants
Start Date 2025-10-21
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-21